BE823689A - Compositions pharmaceutiques - Google Patents
Compositions pharmaceutiquesInfo
- Publication number
- BE823689A BE823689A BE151793A BE151793A BE823689A BE 823689 A BE823689 A BE 823689A BE 151793 A BE151793 A BE 151793A BE 151793 A BE151793 A BE 151793A BE 823689 A BE823689 A BE 823689A
- Authority
- BE
- Belgium
- Prior art keywords
- pharmaceutical compositions
- pharmaceutical
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2365103A DE2365103C3 (de) | 1973-12-21 | 1973-12-21 | V erwendung von Hormonen zur Kontrazeption |
Publications (1)
Publication Number | Publication Date |
---|---|
BE823689A true BE823689A (fr) | 1975-06-20 |
Family
ID=5902211
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE151793A BE823689A (fr) | 1973-12-21 | 1974-12-20 | Compositions pharmaceutiques |
Country Status (13)
Country | Link |
---|---|
US (1) | US3957982A (fr) |
BE (1) | BE823689A (fr) |
CA (1) | CA1029303A (fr) |
CY (1) | CY1065A (fr) |
DE (1) | DE2365103C3 (fr) |
DK (1) | DK155308C (fr) |
GB (1) | GB1490099A (fr) |
HK (1) | HK47080A (fr) |
KE (1) | KE3059A (fr) |
MY (1) | MY8100118A (fr) |
NL (1) | NL178845C (fr) |
SE (1) | SE441233B (fr) |
ZA (1) | ZA748128B (fr) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8071577B2 (en) | 2004-04-20 | 2011-12-06 | Bayer Pharma Aktiengesellschaft | Multi-phase contraceptive preparation based on a natural estrogen |
US8153616B2 (en) | 2005-10-17 | 2012-04-10 | Bayer Pharma Aktiengesellschaft | Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same |
US8349820B2 (en) | 2006-10-20 | 2013-01-08 | Bayer Pharma Aktiengesellschaft | Use of estradiol valerate or 17β-estradiol in combination with dienogest for oral therapy to maintain and/or increase feminine libido |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4292315A (en) * | 1977-12-30 | 1981-09-29 | Nichols Vorys | Follicular phase estrogen or progestin with physiologic estrogen/progestin luteal phase replacement drug delivery system |
NL8001593A (nl) * | 1980-03-18 | 1981-10-16 | Akzo Nv | Meerfasisch combinatiepreparaat voor orale anticonceptie. |
DE3029726A1 (de) * | 1980-08-06 | 1982-02-25 | Werner Dr.med. 4400 Münster Steinschulte | Postkoitale kontrazeptiva mit norgestrel oder levonorgestrel |
US4425339A (en) | 1981-04-09 | 1984-01-10 | Syntex (U.S.A.) Inc. | Treatment of menopausal symptoms |
US4390531A (en) * | 1981-08-10 | 1983-06-28 | Syntex Pharmaceuticals International Ltd. | Method of contraception using peak progestogen dosage |
US4826831A (en) * | 1983-08-05 | 1989-05-02 | Pre Jay Holdings Limited | Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens |
AU582540B2 (en) * | 1983-08-05 | 1989-04-06 | Pre Jay Holdings Ltd. | A method of hormonal treatment of perimenopausal, menopausal and post-menopausal disorders and multi-preparation pack therefor |
DE3347125A1 (de) * | 1983-12-22 | 1985-07-11 | Schering AG, 1000 Berlin und 4709 Bergkamen | Mehrstufenkombinationspraeparat und seine verwendung zur oralen kontrazeption |
US4610687A (en) * | 1984-08-06 | 1986-09-09 | Board Of Trustees Operating Michigan State University | Method for breeding control in female bovines |
US5010070A (en) * | 1987-06-15 | 1991-04-23 | Warner-Lambert Company | Graduated estrogen contraceptive |
US4816257A (en) * | 1985-09-20 | 1989-03-28 | Research & Education Institute, Harbor-Ucla Medical Center Inc. | Method for producing an in vivo environment suitable for human embryo transfer |
US4958736A (en) * | 1986-03-18 | 1990-09-25 | Gynex, Inc. | Package for oral contraceptive tablet |
US4762717A (en) * | 1986-03-21 | 1988-08-09 | The General Hospital Corporation | Continuous delivery of luteinizing hormone releasing hormone compositions in combination with sex steroid delivery for use as a contraceptive |
IE61236B1 (en) † | 1986-07-15 | 1994-10-19 | American Home Prod | Combination dosage form for pre-menopausal women |
US5276022A (en) * | 1987-09-24 | 1994-01-04 | Jencap Research Ltd. | Hormone preparation and method |
US5108995A (en) * | 1987-09-24 | 1992-04-28 | Jencap Research Ltd. | Hormone preparation and method |
CA1336328C (fr) * | 1988-04-11 | 1995-07-18 | Walter G. Leonard | Methode pour augmenter la densite osseuse chez l'etre humain |
IE67345B1 (en) * | 1991-03-12 | 1996-03-20 | Akzo Nv | Low dose dry pharmaceutical preparations |
US6407082B1 (en) * | 1996-09-13 | 2002-06-18 | New Life Pharmaceuticals Inc. | Prevention of ovarian cancer by administration of a vitamin D compound |
US5747480A (en) * | 1996-05-08 | 1998-05-05 | American Home Products Corporation | Oral contraceptive |
US6479475B1 (en) | 1996-07-26 | 2002-11-12 | Wyeth | Oral contraceptive |
DK0917466T3 (da) * | 1996-07-26 | 2004-12-20 | Wyeth Corp | Oralt antikonceptionsmiddel |
US5858405A (en) * | 1996-07-26 | 1999-01-12 | American Home Products Corporation | Oral contraceptive |
US5888543A (en) * | 1996-07-26 | 1999-03-30 | American Home Products Corporation | Oral contraceptives |
US6451778B1 (en) | 1996-07-26 | 2002-09-17 | Wyeth | Oral contraceptive |
US6765002B2 (en) | 2000-03-21 | 2004-07-20 | Gustavo Rodriguez | Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium |
US6028064A (en) | 1996-09-13 | 2000-02-22 | New Life Pharmaceuticals Inc. | Prevention of ovarian cancer by administration of progestin products |
US6034074A (en) | 1996-09-13 | 2000-03-07 | New Life Pharmaceuticals Inc. | Prevention of ovarian cancer by administration of a Vitamin D compound |
US6511970B1 (en) | 1996-09-13 | 2003-01-28 | New Life Pharmaceuticals Inc. | Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium |
US20050038006A1 (en) * | 1998-12-23 | 2005-02-17 | Shangold Gary A. | Triphasic oral contraceptive |
US6214815B1 (en) | 1998-12-23 | 2001-04-10 | Ortho-Mcneil Pharmaceuticals, Inc. | Triphasic oral contraceptive |
US6855703B1 (en) | 2000-03-10 | 2005-02-15 | Endeavor Pharmaceuticals | Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds |
US6660726B2 (en) * | 2000-03-10 | 2003-12-09 | Endeavor Pharmaceuticals | Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same |
US7989436B2 (en) | 2003-07-23 | 2011-08-02 | Duramed Pharmaceuticals, Inc. | Estrogenic compounds and pharmaceutical formulations comprising the same |
US7459445B2 (en) * | 2000-03-10 | 2008-12-02 | Duramed Pharmaceuticals, Inc. | Estrogenic compounds and topical pharmaceutical formulations of the same |
US20050113351A1 (en) * | 2000-03-21 | 2005-05-26 | Rodriguez Gustavo C. | Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium |
US20010044431A1 (en) * | 2000-03-21 | 2001-11-22 | Rodriguez Gustavo C. | Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium |
US20040176336A1 (en) * | 2000-03-21 | 2004-09-09 | Rodriguez Gustavo C. | Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium |
DE10045380A1 (de) * | 2000-09-14 | 2002-04-04 | Schering Ag | Verfahren zur Kontrazeption und dessen Darreichungsform |
US6992075B2 (en) * | 2003-04-04 | 2006-01-31 | Barr Laboratories, Inc. | C(14) estrogenic compounds |
WO2004091535A2 (fr) * | 2003-04-11 | 2004-10-28 | Barr Laboratories, Inc. | Procede d'administration d'oestrogenes et de progestatifs |
EP1853272A1 (fr) * | 2005-02-03 | 2007-11-14 | Duramed Pharmaceuticals, Inc. | Compositions d'oestrogenes non conjugues et procedes destines a leur utilisation |
US11376263B2 (en) | 2020-10-08 | 2022-07-05 | Fortress Biotech, Inc. | Cyproterone acetate compositions and uses thereof |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL6615481A (fr) * | 1966-11-02 | 1968-05-03 | ||
US3568828A (en) * | 1967-03-01 | 1971-03-09 | Squibb & Sons Inc | Modified sequential oral contraceptive |
US3639600A (en) * | 1969-08-28 | 1972-02-01 | Upjohn Co | Process of establishing cyclicity in a human female |
US3795734A (en) * | 1970-04-20 | 1974-03-05 | American Home Prod | Cyclic regimen of hormone administration for contraception |
US3733407A (en) * | 1971-08-25 | 1973-05-15 | Syntex Corp | Menopause treatment |
DE2310963A1 (de) * | 1972-04-14 | 1974-09-05 | Schering Ag | Methode zur kontrazeption durch verabfolgung von stufenkombinationspraeparaten |
DE2335265A1 (de) * | 1973-07-09 | 1975-01-30 | Schering Ag | Methode zur kontrazeption durch verabfolgung von stufenkombinationspraeparaten |
-
1973
- 1973-12-21 DE DE2365103A patent/DE2365103C3/de not_active Expired
-
1974
- 1974-12-19 DK DK667674A patent/DK155308C/da not_active IP Right Cessation
- 1974-12-19 SE SE7416039A patent/SE441233B/xx not_active IP Right Cessation
- 1974-12-20 CA CA216,593A patent/CA1029303A/fr not_active Expired
- 1974-12-20 BE BE151793A patent/BE823689A/fr not_active IP Right Cessation
- 1974-12-20 ZA ZA00748128A patent/ZA748128B/xx unknown
- 1974-12-23 US US05/535,575 patent/US3957982A/en not_active Expired - Lifetime
- 1974-12-23 NL NLAANVRAGE7416807,A patent/NL178845C/xx not_active IP Right Cessation
- 1974-12-23 CY CY1065A patent/CY1065A/xx unknown
- 1974-12-23 GB GB55528/74A patent/GB1490099A/en not_active Expired
-
1980
- 1980-06-24 KE KE3059A patent/KE3059A/xx unknown
- 1980-08-28 HK HK470/80A patent/HK47080A/xx unknown
-
1981
- 1981-12-30 MY MY118/81A patent/MY8100118A/xx unknown
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8071577B2 (en) | 2004-04-20 | 2011-12-06 | Bayer Pharma Aktiengesellschaft | Multi-phase contraceptive preparation based on a natural estrogen |
US8153616B2 (en) | 2005-10-17 | 2012-04-10 | Bayer Pharma Aktiengesellschaft | Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same |
US8349820B2 (en) | 2006-10-20 | 2013-01-08 | Bayer Pharma Aktiengesellschaft | Use of estradiol valerate or 17β-estradiol in combination with dienogest for oral therapy to maintain and/or increase feminine libido |
Also Published As
Publication number | Publication date |
---|---|
DK667674A (fr) | 1975-09-08 |
KE3059A (en) | 1980-07-11 |
MY8100118A (en) | 1981-12-31 |
US3957982A (en) | 1976-05-18 |
ZA748128B (en) | 1976-01-28 |
HK47080A (en) | 1980-09-05 |
SE7416039L (fr) | 1975-06-23 |
AU7670874A (en) | 1976-06-24 |
DE2365103C3 (de) | 1980-08-28 |
CA1029303A (fr) | 1978-04-11 |
NL178845B (nl) | 1986-01-02 |
SE441233B (sv) | 1985-09-23 |
NL178845C (nl) | 1986-06-02 |
NL7416807A (nl) | 1975-06-24 |
DK155308C (da) | 1989-08-28 |
DE2365103B2 (de) | 1979-12-20 |
DK155308B (da) | 1989-03-28 |
DE2365103A1 (de) | 1975-07-10 |
GB1490099A (en) | 1977-10-26 |
CY1065A (en) | 1980-10-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BE823689A (fr) | Compositions pharmaceutiques | |
BE772190A (fr) | Nouvelles compositions pharmaceutiques | |
IT1027014B (it) | Composizione antitraspirante | |
BR7409822A (pt) | Composicao adstringente | |
IT1046789B (it) | Composizioni dentarie | |
AR220095A1 (es) | Composiciones cosmeticas | |
AT353972B (de) | Zahnpflegemittel | |
BE782981A (fr) | Compositions pharmaceutiques | |
BE814037A (fr) | Compositions dentaires | |
AT335619B (de) | Zahnpflegemittel | |
BR7401599D0 (pt) | Composicoes organosilicas | |
BE817757A (fr) | Compositions pharmaceutiques cardiotoniques | |
SE7806024L (sv) | Hydroherdbara kompositioner | |
BE809473A (fr) | Compositions dentrifrices | |
BE809378A (fr) | Compositions pharmaceutiques comprenant des sulfonamides | |
BE816214A (fr) | Nouvelles compositions therapeutiques | |
BR7404915D0 (pt) | Composicoes cosmeticas | |
BE817427A (fr) | Compositions pharmaceutiques | |
BE782444A (fr) | Compositions pharmaceutiques | |
AT344916B (de) | Zahnpflegemittel | |
SE7711779L (sv) | Farmaceutiska kompositioner | |
BE764768A (fr) | Compositions pharmaceutiques | |
RO70571A (fr) | Composition herbicide synergetique liquide | |
RO71539A (fr) | Composition herbicide sinergetique | |
FR2285871A1 (fr) | Compositions pharmaceutiques |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RE20 | Patent expired |
Owner name: SCHERING A.G. Effective date: 19941220 |